The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Smirnova O.V.

Sklifosovsky Research Institute for Emergency Care

Ovcharenko E.S.

Research Institute for the Medical Problems of the North — Krasnoyarsk Research Center of the Russian Academy of Sciences

Kasparov E.V.

Research Institute for the Medical Problems of the North — Krasnoyarsk Research Center of the Russian Academy of Sciences

Sinyakov A.A.

Research Institute for the Medical Problems of the North — Krasnoyarsk Research Center of the Russian Academy of Sciences

Characteristics of the phagocytic component of the immune system in early-stage gastric cancer

Authors:

Smirnova O.V., Ovcharenko E.S., Kasparov E.V., Sinyakov A.A.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2023;12(4): 30‑34

Read: 1938 times


To cite this article:

Smirnova OV, Ovcharenko ES, Kasparov EV, Sinyakov AA. Characteristics of the phagocytic component of the immune system in early-stage gastric cancer. P.A. Herzen Journal of Oncology. 2023;12(4):30‑34. (In Russ.)
https://doi.org/10.17116/onkolog20231204130

Recommended articles:
Arti­ficial inte­lligence in reproductive medi­cine and surgery. Russian Journal of Human Reproduction. 2025;(4):10-25
The impo­rtance of screening preventive examination at the outpatient stage. Russian Journal of Preventive Medi­cine. 2025;(10):99-102

References:

  1. Toigonbekov A, Akhunbaev S, Umetov M, Tumanbaev AN. Some intense and standardized stomach cancer disease indicators in the Kyrgyz republic. Bulletin of Science and Practice. 2020;6(7):169-175.  https://doi.org/10.33619/2414-2948/56/20
  2. Budurov MD, Davydov MM, Ibraev MA, Fedyanin MYu, Malikhova OA. A clinical case of long-term remission of disseminated gastric cancer. P.A. Herzen Journal of Oncology. 2018;7(6):48-51. (In Russ.). https://doi.org/10.17116/onkolog2018706148
  3. Fu DG. Epigenetic alterations in gastric cancer (Review). Mol Med Rep. 2015;12(3):3223-3230. https://doi.org/10.3892/mmr.2015.3816
  4. Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23(5):700-713.  https://doi.org/10.1158/1055-9965.EPI-13-1057
  5. Gorbunova EA, Medvedeva NN, Filkin GN. Somatometric and index indicators for assessing the physical state of patients with gastric cancer. Acta Biomedica Scientifica. 2018;3(6):77-81. (In Russ.). https://doi.org/10.29413/ABS.2018-3.6.10
  6. https://doi.org/10.24411/2687-0053-2020-1007 
  7. den Hoed CM, Kuipers EJ. Gastric cancer: how can we reduce the incidence of this disease? Curr Gastroenterol Rep. 2016;18(7):34.  https://doi.org/10.1007/s11894-016-0506-0
  8. Yusefi AR, Bagheri Lankarani K, Bastani P, Radinmanesh M, Kavosi Z. Risk factors for gastric cancer: a systematic review. Asian Pac J Cancer Prev. 2018;19(3):591-603.  https://doi.org/10.22034/APJCP.2018.19.3.591
  9. Ang TL, Fock KM. Clinical epidemiology of gastric cancer. Singapore Med J. 2014;55(12):621-628.  https://doi.org/10.11622/smedj.2014174
  10. Khomyakov VM, Yermoshina AD, Pirogov SS, Ryabov AB. Stomach cancer risk factors: the modern concept. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2017;27(6):78-86. (In Russ.).
  11. Musaelyan AA, Nazarov VD, Lapin SV, Boriskin AG, Reva SA, Lebedev DG, Yakovlev VD, Viktorov DA, Toropovskii AN, Emanuel VL, Al-Shukri SKh, Petrov SB. Diagnostic value of PCA3, TMPRSS2:ERG and prostatic specific antigen derivatives in the detection of prostate cancer. Cancer Urology. 2020;16(2):65-73. (In Russ.). https://doi.org/10.17650/1726-9776-2020-16-2-65-73
  12. Khakimova G G, Tryakin A A, Zabotina T N, Khakimova Sh G. Comprehensive assessment of the systemic and local immunity, inflammatory factors and clinical indicators in patients with gastric cancer. Malignant tumours. Malignant Tumours. 2020;10(4):5-15. (In Russ.). https://doi.org/10.18027/2224-5057-2020-10-4-5-15
  13. Liew PX, Kubes P. The neutrophil’s role during health and disease. Physiol Rev. 2019;99(2):1223-1248. https://doi.org/10.1152/physrev.00012.2018
  14. Dolgushin II, Mezentseva EA, Savochkina AYu, Kuznetsova EK. Neutrophil as a multifunctional relay in immune system. Russian Journal of Infection and Immunity. 2019;9(1):9-38. (In Russ.). https://doi.org/10.15789/2220-7619-2019-1-9-38
  15. Smirnova OV, Kasparov EV, Perepechai YaI, Versenev AA, Laletin IA. The features of nonspecific immunity in the progression of colorectal cancer. Experimental and Clinical Gastroenterology. 2018;153(5):73-77. (In Russ.).
  16. Svitich OA, Filina AB, Davydova NV, Gankovskaya LV, Zverev VV. The role of innate immunity factors in tumorigenesis process. Medical Immunology. 2018;20(2):151-162. (In Russ.). https://doi.org/10.15789/1563-0625-2018-2-151-162
  17. Sionov RV, Fridlender ZG, Granot Z. The multifaceted roles neutrophils play in the tumor microenvironment. Cancer Microenviron. 2015;8(3):125-158.  https://doi.org/10.1007/s12307-014-0147-5
  18. Preston CC, Goode EL, Hartmann LC, Kalli KR, Knutson KL. Immunity and immune suppression in human ovarian cancer. Immunotherapy. 2011;3(4):539-556.  https://doi.org/10.2217/imt.11.20
  19. Lazar DC, Avram MF, Romoșan I, Cornianu M, Taban S, Goldis A. Prognostic significance of tumor immune microenvironment and immunotherapy: novel insights and future perspectives in gastric cancer. World J Gastroenterol. 2018;24(32):3583-3616. https://doi.org/10.3748/wjg.v24.i32.3583

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.